{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:35:38Z","timestamp":1793968538878,"version":"4.8.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Respiratory syncytial virus (RSV) is recognized as a major cause of wintertime illness in children. Two forms of immunization to protect infants against severe infection have recently been approved. Information on the effects of infections on health-related quality of life (HRQoL) supports well-informed policy decisions. However, validated HRQoL instruments for infants and young children are lacking. We estimated the short-term impact on HRQoL of RSV infection on children, using a new pediatric instrument, and their caregivers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Children \u226436 months of age admitted to a tertiary pediatric hospital with laboratory-confirmed RSV infection were recruited during the 2023\/2024 season. HRQoL loss was assessed prospectively using an experimental multiattribute utility tool (EQ-TIPS V2.0) for children and the established EQ-5D-5L for their primary caregivers, from presentation to recovery, allowing the calculation of quality-adjusted life years (QALY) lost.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Among 103 families recruited, 97 completed at least 3 questionnaires during the study period. The main domains affected in children were \u201ceating\u201d and \u201cpain\u201d and for primary caregivers, \u201canxiety\/depression\u201d and undertaking \u201cusual activities.\u201d The median RSV-associated HRQoL loss for children was 4.7 days [interquartile range (IQR): 4.6\u20135.1] [12.9 QALY\/1000 children (IQR: 12.4\u201314.1)] and for primary caregivers was 3.1 days (IQR 3.0\u20133.3) [8.4 QALY\/1000 caregivers (IQR: 8.3\u20139.0)].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The short-term impact of RSV infection on HRQoL is substantial both for children and their caregivers. Using a HRQoL tool specifically designed for young children delivers higher estimates of loss than previously reported. This study provides important additional information to guide immunization policy recommendations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000004973","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:03:20Z","timestamp":1757441000000},"page":"29-35","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Loss of Health-related Quality of Life Among Hospitalized Children With Respiratory Syncytial Virus and Their Caregivers"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7301-5092","authenticated-orcid":false,"given":"In\u00eas","family":"Taborda","sequence":"first","affiliation":[{"name":"Paediatric Emergency Service and Infectious Diseases Unit, Hospital Pedi\u00e1trico de Coimbra, Unidade Local de Sa\u00fade de Coimbra, Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda","family":"Oben","sequence":"additional","affiliation":[{"name":"School of Engineering Mathematics and Technology"},{"name":"Bristol Vaccine Centre, Cellular and Molecular Medicine and Population Health Sciences, University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Santos Ferreira","sequence":"additional","affiliation":[{"name":"Paediatric Emergency Service and Infectious Diseases Unit, Hospital Pedi\u00e1trico de Coimbra, Unidade Local de Sa\u00fade de Coimbra, Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Alves Costa","sequence":"additional","affiliation":[{"name":"Paediatric Emergency Service and Infectious Diseases Unit, Hospital Pedi\u00e1trico de Coimbra, Unidade Local de Sa\u00fade de Coimbra, Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipa","family":"Curinha","sequence":"additional","affiliation":[{"name":"Paediatric Emergency Service and Infectious Diseases Unit, Hospital Pedi\u00e1trico de Coimbra, Unidade Local de Sa\u00fade de Coimbra, Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Tom\u00e9","sequence":"additional","affiliation":[{"name":"Paediatric Emergency Service and Infectious Diseases Unit, Hospital Pedi\u00e1trico de Coimbra, Unidade Local de Sa\u00fade de Coimbra, Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Marlow","sequence":"additional","affiliation":[{"name":"Bristol Vaccine Centre, Cellular and Molecular Medicine and Population Health Sciences, University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Chatzilena","sequence":"additional","affiliation":[{"name":"School of Engineering Mathematics and Technology"},{"name":"Bristol Vaccine Centre, Cellular and Molecular Medicine and Population Health Sciences, University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Danon","sequence":"additional","affiliation":[{"name":"School of Engineering Mathematics and Technology"},{"name":"Bristol Vaccine Centre, Cellular and Molecular Medicine and Population Health Sciences, University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Finn","sequence":"additional","affiliation":[{"name":"Bristol Vaccine Centre, Cellular and Molecular Medicine and Population Health Sciences, University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Paediatric Emergency Service and Infectious Diseases Unit, Hospital Pedi\u00e1trico de Coimbra, Unidade Local de Sa\u00fade de Coimbra, Coimbra, Portugal"},{"name":"Faculty of Medicine, University of Coimbra, Coimbra, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"R1-20251215","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"R2-20251215","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study.","volume":"390","author":"Shi","year":"2017","journal-title":"Lancet"},{"key":"R3-20251215","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S2213-2600(22)00414-3","article-title":"The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study.","volume":"11","author":"Wildenbeest","year":"2023","journal-title":"Lancet Respir Med"},{"key":"R4-20251215","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1093\/infdis\/jiac150","article-title":"Age-specific estimates of respiratory syncytial virus-associated hospitalizations in 6 European countries: a time series analysis.","volume":"226","author":"Johannesen","year":"2022","journal-title":"J Infect Dis"},{"key":"R6-20251215","doi-asserted-by":"crossref","first-page":"102790","DOI":"10.1016\/j.eclinm.2024.102790","article-title":"An evaluation of 2015\u20132019 United States respiratory syncytial virus hospitalizations as a framework to develop potential strategies for the prevention of the hospital burden among infants.","volume":"75","author":"Suss","year":"2024","journal-title":"EClinicalMedicine"},{"key":"R7-20251215","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s40121-024-00989-0","article-title":"The multifaceted burden of respiratory syncytial virus (RSV) infections in young children on the family: a European study.","volume":"13","author":"Trautmannsberger","year":"2024","journal-title":"Infect Dis Ther"},{"key":"R8-20251215","doi-asserted-by":"crossref","first-page":"e14169","DOI":"10.1111\/pai.14169","article-title":"Parent\u2019s perception of respiratory syncytial virus and subsequent wheezing burden: a multi-country cross-sectional survey.","volume":"35","author":"Custovic","year":"2024","journal-title":"Pediatr Allergy Immunol"},{"key":"R13-20251215","doi-asserted-by":"crossref","first-page":"2300606","DOI":"10.2807\/1560-7917.ES.2023.28.49.2300606","article-title":"Early lessons from the implementation of universal respiratory syncytial virus prophylaxis in infants with long-acting monoclonal antibodies, Galicia, Spain, September and October 2023.","volume":"28","author":"Martin\u00f3n-Torres","year":"2023","journal-title":"Euro Surveill"},{"key":"R17-20251215","doi-asserted-by":"crossref","first-page":"e13066","DOI":"10.1111\/irv.13066","article-title":"Burden and severity of children\u2019s hospitalizations by respiratory syncytial virus in Portugal, 2015\u20132018.","volume":"17","author":"Bandeira","year":"2023","journal-title":"Influenza Other Respir Viruses"},{"key":"R18-20251215","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.vaccine.2023.01.058","article-title":"Cost-effectiveness of monoclonal antibody and maternal immunization against respiratory syncytial virus (RSV) in infants: evaluation for six European countries.","volume":"41","author":"Getaneh","year":"2023","journal-title":"Vaccine"},{"key":"R19-20251215","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1016\/j.vaccine.2023.03.024","article-title":"Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: a multi-country prospective cohort study in Europe.","volume":"41","author":"Mao","year":"2023","journal-title":"Vaccine"},{"key":"R20-20251215","doi-asserted-by":"crossref","first-page":"S236","DOI":"10.1093\/infdis\/jiac183","article-title":"Impact of respiratory syncytial virus on child, caregiver, and family quality of life in the United States: systematic literature review and analysis.","volume":"226","author":"Glaser","year":"2022","journal-title":"J Infect Dis"},{"key":"R21-20251215","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/diseases11040126","article-title":"The estimate of parental quality of life loss due to respiratory syncytial virus (RSV) hospitalization.","volume":"11","author":"Wrotek","year":"2023","journal-title":"Diseases"},{"key":"R22-20251215","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1186\/s12879-021-06629-z","article-title":"The impact of childhood RSV infection on children\u2019s and parents\u2019 quality of life: a prospective multicenter study in Spain.","volume":"21","author":"D\u00edez-Gand\u00eda","year":"2021","journal-title":"BMC Infect Dis"},{"key":"R23-20251215","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s41687-020-00251-4","article-title":"Validity and reliability testing of the toddler and infant (TANDI) health related quality of life instrument for very young children.","volume":"4","author":"Verstraete","year":"2020","journal-title":"J Patient Rep Outcomes"},{"key":"R24-20251215","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12955-020-1271-1","article-title":"Item generation for a proxy health related quality of life measure in very young children.","volume":"18","author":"Verstraete","year":"2020","journal-title":"Health Qual Life Outcomes"},{"key":"R27-20251215","doi-asserted-by":"crossref","first-page":"e0157665","DOI":"10.1371\/journal.pone.0157665","article-title":"Development and validation of a new clinical scale for infants with acute respiratory infection: the ReSVinet scale.","volume":"11","author":"Justicia-Grande","year":"2016","journal-title":"PLoS One"},{"key":"R29-20251215","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1007\/s11136-019-02226-5","article-title":"A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.","volume":"28","author":"Ferreira","year":"2019","journal-title":"Qual Life Res"},{"key":"R31-20251215","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/diseases11040126","article-title":"The impact of RSV hospitalization on children\u2019s quality of life.","volume":"11","author":"Wrotek","year":"2023","journal-title":"Diseases"},{"key":"R32-20251215","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/INF.0000000000004360","article-title":"Assessing the burden of respiratory syncytial virus-related bronchiolitis in primary care and at 15-day and 6-month follow-up before prophylaxis in France: a test-negative study.","volume":"43","author":"Rybak","year":"2024","journal-title":"Pediatr Infect Dis J"},{"key":"R33-20251215","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/irv.12686","article-title":"Estimates for quality of life loss due to respiratory syncytial virus.","volume":"14","author":"Hodgson","year":"2020","journal-title":"Influenza Other Respir Viruses"},{"key":"R34-20251215","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12955-018-0840-z","article-title":"Influence of the child\u2019s perceived general health on the primary caregiver\u2019s health status.","volume":"16","author":"Verstraete","year":"2018","journal-title":"Health Qual Life Outcomes"},{"key":"R35-20251215","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1016\/j.vaccine.2015.07.012","article-title":"Quality of life impacts from rotavirus gastroenteritis on children and their families in the UK.","volume":"33","author":"Marlow","year":"2015","journal-title":"Vaccine"},{"key":"R36-20251215","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.vaccine.2022.12.011","article-title":"Prospective study of loss of health-related quality adjusted life years in children and their families due to uncomplicated and hospitalised varicella.","volume":"41","author":"Rodrigues","year":"2023","journal-title":"Vaccine"},{"key":"R37-20251215","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jval.2018.12.009","article-title":"Valuing health status in the first year of life: the infant health-related quality of life instrument.","volume":"22","author":"Jabrayilov","year":"2019","journal-title":"Value Health"},{"key":"R38-20251215","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11136-006-9134-8","article-title":"Reliability and validity of the Infant and Toddler Quality of Life Questionnaire (ITQOL) in a general population and respiratory disease sample.","volume":"16","author":"Raat","year":"2007","journal-title":"Qual Life Res"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004973","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:01:00Z","timestamp":1765803660000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004973","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,3]]}}}